Issue 1/2019
Content (26 Articles)
Effects of physical and mind–body exercise on sleep problems during and after breast cancer treatment: a systematic review and meta-analysis
Charlotte Kreutz, Martina E. Schmidt, Karen Steindorf
Randomised clinical endpoint studies for trastuzumab biosimilars: a systematic review
Michael Coory, Kate Thornton
Higher ER load is not associated with better outcome in stage 1–3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer
I. Noordhoek, A. F. de Groot, D. Cohen, G. J. Liefers, J. E. A. Portielje, J. R. Kroep
Systematic review of economic evaluations of exercise and physiotherapy for patients treated for breast cancer
Kamran Ahmad Khan, Bruno Mazuquin, Alastair Canaway, Stavros Petrou, Julie Bruce
The relation between stressful life events and breast cancer: a systematic review and meta-analysis of cohort studies
Narjes Bahri, Tahereh Fathi Najafi, Fatemeh Homaei Shandiz, Hamid Reza Tohidinik, Abdoljavad Khajavi
Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer
Sasagu Kurozumi, Chitra Joseph, Sara Raafat, Sultan Sonbul, Yousif Kariri, Sami Alsaeed, Marian Pigera, Mansour Alsaleem, Christopher C. Nolan, Simon J. Johnston, Mohammed A. Aleskandarany, Angela Ogden, Takaaki Fujii, Ken Shirabe, Stewart G. Martin, Ibraheem Alshankyty, Nigel P. Mongan, Ian O. Ellis, Andrew R. Green, Emad A. Rakha
Prognostic value of tumor cell DNA content determined by flow cytometry using formalin-fixed paraffin-embedded breast cancer tissues
Hiroki Kusama, Masafumi Shimoda, Tomohiro Miyake, Tomonori Tanei, Naofumi Kagara, Yasuto Naoi, Kenzo Shimazu, Seung Jin Kim, Shinzaburo Noguchi
Breast cancer research and treatment reconstruction of unilateral breast structure using three-dimensional ultrasound imaging to assess breast neoplasm
Yuanyuan Lu, Junlai Li, Xiaohui Zhao, Jie Li, Jie Feng, Erlong Fan
Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer
Martin Mutonga, Sedona Speedy, Alfred Rademaker, Dachao Liu, Regina Uthe, Sarika Jain, William J. Gradishar, Lisa Flaum, Cesar A. Santa-Maria
Pathologic discordance to clinical management decisions suggests overtreatment in pediatric benign breast disease
Maggie L. Westfal, Numa P. Perez, Ya-Ching Hung, David C. Chang, Cassandra M. Kelleher
Downregulation of APE1 potentiates breast cancer cells to olaparib by inhibiting PARP-1 expression
Xiaobin Ma, Chengxue Dang, Weili Min, Yan Diao, Wentao Hui, Xiaolong Wang, Zhijun Dai, Xijing Wang, Huafeng Kang
miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway
Jieun Lee, Hee Eun Kim, Young-Seok Song, Eun Yoon Cho, Ahwon Lee
Propagation of functional estrogen receptor positive normal human breast cells in 3D cultures
Peng Meng, Marica Vaapil, Abderrahmane Tagmount, Alex Loguinov, Chris Vulpe, Paul Yaswen
Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants
D. Gareth R. Evans, Elaine F. Harkness, Adam R. Brentnall, Elke M. van Veen, Susan M. Astley, Helen Byers, Sarah Sampson, Jake Southworth, Paula Stavrinos, Sacha J. Howell, Anthony J. Maxwell, Anthony Howell, William G. Newman, Jack Cuzick
GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event
Lucile Montagne, Jocelyn Gal, Marie-Eve Chand, Renaud Schiappa, Alexander T. Falk, Rémy Kinj, Mathieu Gauthier, Jean-Michel Hannoun-Levi
Improving surgical efficiency of immediate implant-based breast reconstruction following mastectomy
Kassandra Nealon, Megan Rebello, Nikhil Sobti, Andrew Sherburne, Dale Spracklin, Eric C. Liao, Michelle Specht
Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms
Rinat Bernstein-Molho, Amihood Singer, Yael Laitman, Iris Netzer, Shelley Zalmanoviz, Eitan Friedman
Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastases
Daniel N. Cagney, Nayan Lamba, Sofia Montoya, Puyao Li, Luke Besse, Allison M. Martin, Rachel H. Brigell, Paul J. Catalano, Paul D. Brown, Jose P. Leone, Shyam K. Tanguturi, Daphne A. Haas-Kogan, Brian M. Alexander, Nancy U. Lin, Ayal A. Aizer
Intrinsic brain activity changes associated with adjuvant chemotherapy in older women with breast cancer: a pilot longitudinal study
Bihong T. Chen, Taihao Jin, Sunita K. Patel, Ningrong Ye, Huiyan Ma, Chi Wah Wong, Russell C. Rockne, James C. Root, Andrew J. Saykin, Tim A. Ahles, Andrei I. Holodny, Neal Prakash, Joanne Mortimer, James Waisman, Yuan Yuan, Daneng Li, Mina S. Sedrak, Jessica Vazquez, Vani Katheria, William Dale
Plasma B-vitamins and one-carbon metabolites and the risk of breast cancer in younger women
Serena C. Houghton, A. Heather Eliassen, Shumin M. Zhang, Jacob Selhub, Bernard A. Rosner, Walter C. Willett, Susan E. Hankinson
Temporal trends and regional variation in the utilization of low-value breast cancer care: has the Choosing Wisely campaign made a difference?
Joan M. Neuner, Ann B. Nattinger, Tina Yen, Emily McGinley, Michael Nattinger, Liliana E. Pezzin
Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
Dominique J. P. van Uden, Marissa C. van Maaren, Peter Bult, Luc J. A. Strobbe, J. J. M. van der Hoeven, Charlotte F. J. M. Blanken-Peeters, Sabine Siesling, Johannes H. W. de Wilt
Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)
Luis Baez-Vallecillo, Akshara S. Raghavendra, Kenneth R. Hess, Carlos H. Barcenas, Stacy L. Moulder, Debu Tripathy, Vicente Valero, Rashmi K. Murthy
The association between mammographic density and breast cancer risk in Western Australian Aboriginal women
Ellie Darcey, Rachel Lloyd, Gemma Cadby, Leanne Pilkington, Andrew Redfern, Sandra C Thompson, Christobel Saunders, Elizabeth Wylie, Jennifer Stone
Impact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patients
Diana Flores-Díaz, Claudia Arce, Lourdes Flores-Luna, Nancy Reynoso-Noveron, Fernando Lara-Medina, Juan Antonio Matus, Enrique Bargallo-Rocha, Víctor Pérez, Cynthia Villarreal-Garza, Paula Cabrera-Galeana, Alejandro Mohar
Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer
Jangsoon Lee, Bora Lim, Troy Pearson, Kuicheon Choi, Jon A. Fuson, Chandra Bartholomeusz, Linda J. Paradiso, Thomas Myers, Debu Tripathy, Naoto T. Ueno